One Size Fits All? Application of Susceptible-Dose-Dependent Breakpoints to Pediatric Patients and Laboratory Reporting-Reference-Cited by-同舟云学术

One Size Fits All? Application of Susceptible-Dose-Dependent Breakpoints to Pediatric Patients and Laboratory Reporting

Published:2019-12-23 Issue:1 Volume:58 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Nielsen Lindsey E.¹,Forrester Jeanne B.²,Girotto Jennifer Ellis³⁴,Dassner Aimee M.⁵,Humphries Romney⁶

Affiliation:

1. University of Nebraska Medical Center, Omaha, Nebraska, USA

2. Atrium Health Levine Children’s, Charlotte, North Carolina, USA

3. Schools of Pharmacy and Medicine, University of Connecticut, Hartford, Connecticut, USA

4. Connecticut Children’s Medical Center, Hartford, Connecticut, USA

5. Children’s Health, Dallas, Texas, USA

6. Accelerate, Phoenix, Arizona, USA

Abstract

The Clinical and Laboratory Standards Institute antimicrobial and antifungal standards define a susceptible-dose-dependent (SDD) category for certain organisms and drug combinations. Reporting MICs within the SDD category suggests that treatment success is likely with increased drug exposure. These breakpoints are based on pharmacokinetic, pharmacodynamic, and clinical outcome data from adults and not pediatric patients.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.01446-19

Reference54 articles.

1. CLSI. 2019. Performance standards for antimicrobial susceptibility testing, 29th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute, Wayne, PA.

2. CLSI. 2017. Performance standards for antifungal susceptibility testing of yeasts, 1st ed. Clinical and Laboratory Standards Institute, Wayne, PA.

3. Intensive care antibiotic consumption and resistance patterns: a cross-correlation analysis

4. Correlations of Antibiotic Use and Carbapenem Resistance in Enterobacteriaceae

5. Pharmacodynamic Analysis of Daptomycin-treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A New Variant of Mutational and Polymorphic Signatures in the ERG11 Gene of Fluconazole-Resistant Candida albicans;Infection and Drug Resistance;2022-06

2. Contemporary Treatment of Resistant Gram-Negative Infections in Pediatric Patients;Infectious Disease Clinics of North America;2022-03

3. Care of the Child with an Infectious Disease or Immunological Defect;Pediatric Diagnostic Labs for Primary Care: An Evidence-based Approach;2022

4. Setting Antimicrobial Susceptibility Testing Breakpoints: A Primer for Pediatric Infectious Diseases Specialists on the Clinical and Laboratory Standards Institute Approach;Journal of the Pediatric Infectious Diseases Society;2021-12-09

5. Knowledge gaps in late-onset neonatal sepsis in preterm neonates: a roadmap for future research;Pediatric Research;2021-09-08